Ventures Associate Director – Immunology & Inflammation

Schrödinger•New York, NY

6d•$185,000 - $235,000•Hybrid

About The Position

Schrödinger seeks a Ventures Associate Director in Immunology and Inflammation to join us in our mission to transform the discovery of therapeutics and materials! Schrödinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Our multidisciplinary drug discovery team also leverages the software platform to advance collaborative programs and its own pipeline of novel therapeutics to address unmet medical needs. As a member of our Therapeutics Group, you’ll leverage your deep research background in immunology, autoimmune biology, and inflammation, as well as your venture experience, to source, evaluate, and incubate the next generation of therapeutic hypotheses and transformative biotech opportunities.

Requirements

PhD in Immunology, Autoimmune Disease, Inflammation, Molecular Biology, Pharmacology, or a closely related biomedical discipline, as well as relevant postdoctoral training
At least one year of work with a recognized venture fellowship program (e.g., Flagship, Arch, Third Rock, Atlas, Corp VC Fellowships, or incubator role) or direct experience as an analyst/associate at a life sciences venture fund or biotech company creation studio
Practical, hands-on experience conducting scientific due diligence, market sizing, competitive landscape mapping, and deal memo preparation
A scientific investor who enjoys bridging the gap between breakthrough science and commercial venture creation
A researcher with a successful track record of high-impact, peer-reviewed publications and deep expertise in immune pathways, inflammatory cascades, and/or mechanisms of inflammaging
A skilled synthesizer of complex biological literature who can ask incisive questions and spot critical flaws or hidden potential in early-stage data
A business strategist who understands early-stage biotech financing, valuation drivers, IP strategy, and drug development lifecycles
An excellent written and verbal communicator who can translate complex scientific concepts into actionable insights for non-technical investors and stakeholders
An entrepreneurial thinker who’s comfortable with ambiguity is excited to build novel therapeutics that address significant unmet medical needs

Responsibilities

Perform rigorous, hypothesis-driven scientific diligence on the landscape of early-stage mechanisms and stealth startups in immunology, autoimmune diseases, chronic inflammation, and age-related immune dysfunction
Critically evaluate preclinical data packages, mechanism-of-action validity, therapeutic differentiation, target tractability, and intellectual property landscapes
Engage with key opinion leaders, academic principal investigators, and clinical experts to validate scientific theses and therapeutic feasibility
Track and map emerging paradigms across academic research institutions, tech transfer offices, and clinical advancements in immunology and inflammation
Source high-quality deal flow by building relationships with founders, venture teams, and incubator ecosystems
Partner with our internal therapeutic team, venture partners, and founders to prioritize and incubate new biotech concepts from ideation through seed stage financing
Assist in crafting development plans, defining target product profiles, mapping the competitive landscape for the target-disease pair and regulatory pathways, and shaping early operational strategy for new co-created ventures
Support ongoing portfolio companies with strategic analysis, board meeting preparation, and follow-on financing efforts